May 03, 2021 2:00 PM
Providing veterans with temporary financial assistance helps them get into stable housing and also reduces their health care costs, according to a nationwide study led by University of Utah Health researchers. Photo credit: Getty Images
Ensuring that veterans have stable housing not only reduces homelessness but also slashes the cost of providing them with publicly funded health care, according to a national study led by University of Utah Health scientists. The researchers found that veterans who received temporary financial assistance (TFA) from the Department of Veterans Affairs (VA) to acquire or retain housing had fewer hospital visits and an average reduction in health care costs of $2,800 over a two-year period than veterans who did not receive this benefit.
Tata Communications - Q4FY21 Result Update - ICICI Securities
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
梁振英倡香港把握 十四五規劃 龐大商機
hkcna.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hkcna.hk Daily Mail and Mail on Sunday newspapers.
Why India should prepare for COVID-19 recovered patients as next big health crisis
downtoearth.org.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from downtoearth.org.in Daily Mail and Mail on Sunday newspapers.
Vetter and Rentschler Biopharma Further Strengthen their Strategic Alliance
LAUPHEIM and RAVENSBURG, Germany, MILFORD, MA, and SKOKIE, IL, USA, April 28, 2021 / B3C newswire / Rentschler Biopharma and Vetter, two globally operating Contract Development and Manufacturing Organizations (CDMOs), announced today that their strategic collaboration has taken key steps forward. The companies have further strengthened the established framework for their alliance and set up a governance structure, as well as implemented guidelines for their joint approach across functions. In parallel to starting their first joint client projects, they are also working closely on existing projects and related topics.
The collaboration was initiated in mid-2020, with the intent to create long-term value through the alignment of manufacturing approaches that enable clients to bring their products to patients more easily and faster. Together, the two CDMOs are mutually enhanc